50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
NASDAQ:IRMD

IRadimed - IRMD Stock Forecast, Price & News

$30.09
-0.45 (-1.47%)
(As of 09/29/2022 12:00 AM ET)
Add
Compare
Today's Range
$28.63
$30.20
50-Day Range
$29.42
$42.25
52-Week Range
$28.18
$55.92
Volume
34,300 shs
Average Volume
59,742 shs
Market Capitalization
$378.08 million
P/E Ratio
31.02
Dividend Yield
N/A
Price Target
$42.00

IRadimed MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
39.6% Upside
$42.00 Price Target
Short Interest
Healthy
2.37% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.85
Upright™ Environmental Score
News Sentiment
0.72mentions of IRadimed in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$115,845 Sold Last Quarter
Proj. Earnings Growth
17.89%
From $0.95 to $1.12 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.06 out of 5 stars

Medical Sector

18th out of 1,097 stocks

Surgical & Medical Instruments Industry

1st out of 107 stocks

IRMD stock logo

About IRadimed (NASDAQ:IRMD) Stock

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Receive IRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IRadimed and its competitors with MarketBeat's FREE daily newsletter.

IRMD Stock News Headlines

See More Headlines
Receive IRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IRadimed and its competitors with MarketBeat's FREE daily newsletter.

IRMD Company Calendar

Last Earnings
7/29/2022
Today
9/29/2022
Next Earnings (Estimated)
11/04/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IRMD
Employees
110
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$42.00
High Stock Price Forecast
$42.00
Low Stock Price Forecast
$42.00
Forecasted Upside/Downside
+39.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$9.32 million
Pretax Margin
28.13%

Debt

Sales & Book Value

Annual Sales
$41.81 million
Cash Flow
$0.89 per share
Book Value
$5.85 per share

Miscellaneous

Free Float
7,074,000
Market Cap
$378.08 million
Optionable
Not Optionable
Beta
1.05

Key Executives

  • Mr. Roger E. Susi (Age 69)
    Founder, Chairman, CEO & Pres
    Comp: $615.27k
  • Mr. Randy Waddell
    VP of Worldwide Sales & Marketing
  • Mr. John F. Glenn (Age 60)
    Chief Financial Officer
  • Mr. Chris Williamson
    Exec. VP of Continuous Improvement & Information Technology
  • Mr. Matt Garner
    Controller













IRMD Stock - Frequently Asked Questions

Should I buy or sell IRadimed stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IRadimed in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" IRMD shares.
View IRMD analyst ratings
or view top-rated stocks.

What is IRadimed's stock price forecast for 2022?

1 brokerages have issued 12 month price objectives for IRadimed's stock. Their IRMD share price forecasts range from $42.00 to $42.00. On average, they predict the company's stock price to reach $42.00 in the next twelve months. This suggests a possible upside of 44.7% from the stock's current price.
View analysts price targets for IRMD
or view top-rated stocks among Wall Street analysts.

How have IRMD shares performed in 2022?

IRadimed's stock was trading at $46.21 on January 1st, 2022. Since then, IRMD shares have decreased by 37.2% and is now trading at $29.02.
View the best growth stocks for 2022 here
.

When is IRadimed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, November 4th 2022.
View our IRMD earnings forecast
.

How were IRadimed's earnings last quarter?

IRadimed Co. (NASDAQ:IRMD) posted its earnings results on Friday, July, 29th. The medical equipment provider reported $0.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.20 by $0.06. The medical equipment provider had revenue of $12.72 million for the quarter, compared to analysts' expectations of $12.64 million. IRadimed had a net margin of 25.42% and a trailing twelve-month return on equity of 18.11%.

How often does IRadimed pay dividends? What is the dividend yield for IRadimed?

IRadimed declared a dividend on Monday, February 7th. Stockholders of record on Thursday, February 17th will be paid a dividend of $1.00 per share on Thursday, February 24th. The ex-dividend date is Wednesday, February 16th.
Read our dividend analysis for IRMD
.

What guidance has IRadimed issued on next quarter's earnings?

IRadimed issued an update on its third quarter 2022 earnings guidance on Friday, August, 5th. The company provided EPS guidance of $0.22-$0.25 for the period, compared to the consensus earnings per share estimate of $0.25. The company issued revenue guidance of $13.10 million-$13.30 million, compared to the consensus revenue estimate of $13.07 million.

What other stocks do shareholders of IRadimed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IRadimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Alphabet (GOOG), Mastercard (MA), Micron Technology (MU), PayPal (PYPL), CRISPR Therapeutics (CRSP), IntriCon (IIN), QUALCOMM (QCOM) and Twitter (TWTR).

What is IRadimed's stock symbol?

IRadimed trades on the NASDAQ under the ticker symbol "IRMD."

How do I buy shares of IRadimed?

Shares of IRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IRadimed's stock price today?

One share of IRMD stock can currently be purchased for approximately $29.02.

How much money does IRadimed make?

IRadimed (NASDAQ:IRMD) has a market capitalization of $364.49 million and generates $41.81 million in revenue each year. The medical equipment provider earns $9.32 million in net income (profit) each year or $0.97 on an earnings per share basis.

How many employees does IRadimed have?

The company employs 110 workers across the globe.

How can I contact IRadimed?

IRadimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The official website for the company is www.iradimed.com. The medical equipment provider can be reached via phone at (407) 677-8022, via email at investorrelations@iradimed.com, or via fax at 407-677-5037.

This page (NASDAQ:IRMD) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.